Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Hazard Mater ; 473: 134691, 2024 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-38788584

RESUMO

Soot nanoparticles (SNPs) are black carbon prevalent in atmospheric environment with significant impacts on public health, leading to neurodegenerative diseases including development of Parkinson's disease (PD). This study investigated the effects of SNPs exposure on PD symptoms, employing both in vivo and in vitro PD models. In the in vivo experiments, animal behavior assessments showed that SNPs exposure exacerbated motor and cognitive impairments in PD mice. Molecular biology techniques further unveiled that SNPs aggravated degeneration of dopaminergic neurons. In vitro experiments revealed that SNPs exposure intensified ferroptosis of PD cells by increasing reactive oxygen species and iron ion levels, while reducing glutathione levels and mitochondrial membrane potential. Sequencing tests indicated elevated N6-methyladenosine (m6A) alteration of the ferroptosis-related protein, acyl-CoA synthetase long chain family member 4 (ACSL4). This study demonstrates that SNPs may exacerbate the onset and progression of PD by recruiting YTH domain-containing family protein 1 (YTHDF1) protein, enhancing m6A methylation in the ACSL4 5'UTR, amplifying ACSL4 protein expression, and accelerating the ferroptosis process in dopaminergic neurons. These molecular mechanisms underlying SNPs exacerbation of PD development may provide crucial insights for formulating environmental safety regulations and potential therapeutic strategies addressing PD in populations residing in regions with varied air quality.


Assuntos
Adenosina , Neurônios Dopaminérgicos , Ferroptose , Camundongos Endogâmicos C57BL , Nanopartículas , Doença de Parkinson , Animais , Neurônios Dopaminérgicos/efeitos dos fármacos , Neurônios Dopaminérgicos/metabolismo , Ferroptose/efeitos dos fármacos , Adenosina/análogos & derivados , Doença de Parkinson/genética , Doença de Parkinson/metabolismo , Nanopartículas/toxicidade , Nanopartículas/química , Coenzima A Ligases/genética , Coenzima A Ligases/metabolismo , Masculino , Metilação/efeitos dos fármacos , Camundongos , Espécies Reativas de Oxigênio/metabolismo , Humanos , RNA , Metilação de RNA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA